Erica Palesandro

Turin, 10064, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Is [177Lu]Lu-PSMA-617 Redefining Value in mCRPC Care? A Meta-Analysis of Clinical and Economic Endpoints.

Is [177Lu]Lu-PSMA-617 Redefining Value in mCRPC Care? A Meta-Analysis of Clinical and Economic Endpoints.

Journal: Cancers

Published: May 27, 2025

Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data.

Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data.

Journal: Cancers

Published: March 01, 2025

Management of gastrointestinal adverse effects in immune-based combination therapy for advanced renal carcinoma: when the oncologist meets the gastroenterologist.

Management of gastrointestinal adverse effects in immune-based combination therapy for advanced renal carcinoma: when the oncologist meets the gastroenterologist.

Journal: Therapeutic advances in gastroenterology

Published: January 24, 2025

Endocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: Practical expert-based management recommendations.

Endocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: Practical expert-based management recommendations.

Journal: Critical reviews in oncology/hematology

Published: September 24, 2024

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives.

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives.

Journal: Clinical genitourinary cancer

Published: April 25, 2024

Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials.

Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials.

Journal: Cancer treatment reviews

Published: December 29, 2023

Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.

Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 21, 2021

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.

Journal: Critical reviews in oncology/hematology

Published: November 09, 2020

SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit.

SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit.

Journal: Frontiers in oncology

Published: June 10, 2020

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.

Journal: Journal of translational medicine

Published: May 30, 2019

Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience.

Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience.

Journal: Anticancer research

Published: May 22, 2018

Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour.

Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 13, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026